Anebulo Pharmaceuticals (ANEB) News Today $2.46 -0.04 (-1.60%) As of 10:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ANEB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Anebulo Pharmaceuticals (ANEB) Projected to Post Quarterly Earnings on WednesdaySeptember 17 at 2:06 AM | marketbeat.comAnebulo Pharmaceuticals provides update on going private transactionSeptember 12, 2025 | msn.comAnebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic AlternativesSeptember 12, 2025 | businesswire.comAnebulo Pharmaceuticals (NASDAQ:ANEB) Stock Price Down 0.8% - Here's What HappenedSeptember 1, 2025 | marketbeat.comShort Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Rises By 878.1%August 16, 2025 | marketbeat.comAnebulo Pharmaceuticals (NASDAQ:ANEB) Shares Down 11.1% - What's Next?August 9, 2025 | marketbeat.comCannabis Use Disorder (CUD) Pipeline Market Research Report 2025 Featuring Aelis Farma, Anebulo Pharmaceuticals, and IndiviorJuly 25, 2025 | finance.yahoo.comMaxim Group Downgrades Anebulo Pharmaceuticals (ANEB)July 25, 2025 | msn.comAnebulo Pharmaceuticals' (ANEB) "Hold" Rating Reaffirmed at Maxim GroupJuly 24, 2025 | marketbeat.comAnebulo Pharmaceuticals stock soars after approving plan to go privateJuly 23, 2025 | investing.comAnebulo Pharmaceuticals shares surge 80% after board approves plan to go privateJuly 23, 2025 | msn.comAnebulo approves reverse stock split ahead of going-private transactionJuly 23, 2025 | msn.comAnebulo Pharmaceuticals (NASDAQ:ANEB) Trading 1.9% Higher - Here's WhyJuly 17, 2025 | marketbeat.comAnebulo Pharmaceuticals (NASDAQ:ANEB) Stock Price Down 1.3% - Should You Sell?June 25, 2025 | marketbeat.comAnebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent UpdatesMay 13, 2025 | businesswire.comHere's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn SituationApril 27, 2025 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS) and Stoke Therapeutics (STOK)March 19, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), BioLife Solutions (BLFS) and Surgery Partners (SGRY)March 4, 2025 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Anebulo Pharmaceuticals (ANEB) and AMN Healthcare Services (AMN)February 25, 2025 | markets.businessinsider.comAnebulo Pharmaceuticals files to sell 15.15M shares of common stock for holdersFebruary 20, 2025 | markets.businessinsider.comAnebulo Pharmaceuticals reports Q4 EPS (9c) vs. (11c) last yearFebruary 14, 2025 | markets.businessinsider.comAnebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent UpdatesFebruary 14, 2025 | businesswire.comAnebulo Pharmaceuticals sets annual meeting for April 4, 2025February 12, 2025 | msn.comAnebulo Pharmaceuticals Leads This Trio Of US Penny StocksFebruary 4, 2025 | uk.finance.yahoo.com3 US Penny Stocks With Market Caps Under $800MDecember 30, 2024 | uk.finance.yahoo.comAnebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Director Purchases $9,999,999.90 in StockDecember 27, 2024 | insidertrades.comAnebulo Pharmaceuticals collaborates with FDA to advance selonabantDecember 24, 2024 | finance.yahoo.comAnebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital RaiseDecember 23, 2024 | businesswire.comAnebulo Pharmaceuticals Advances Cannabis Toxicity SolutionsNovember 15, 2024 | tipranks.comAnebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent UpdatesNovember 13, 2024 | finance.yahoo.comBenchmark maintains Speculative Buy on Anebulo stockOctober 3, 2024 | uk.investing.comAnebulo Pharmaceuticals (NASDAQ:ANEB) Stock Rating Reaffirmed by BenchmarkOctober 1, 2024 | marketbeat.comAnebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent UpdatesSeptember 25, 2024 | finance.yahoo.comAnebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 12.8% in AugustSeptember 16, 2024 | marketbeat.comANEB Anebulo Pharmaceuticals, Inc.July 28, 2024 | seekingalpha.comAnebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic EffectsJuly 22, 2024 | businesswire.comANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024May 15, 2024 | investorplace.comAnebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent UpdatesMay 15, 2024 | finance.yahoo.comGalehead Development to Collaborate With Rivian Automotive on Renewable Energy Project DevelopmentMay 15, 2024 | businesswire.comAnebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Significant Drop in Short InterestMay 14, 2024 | marketbeat.comAnebulo Pharmaceuticals Inc 214April 17, 2024 | morningstar.comMShort Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Rises By 308.7%April 10, 2024 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Acrivon Therapeutics, Inc. (ACRV), Abivax SA Sponsored ADR (ABVX)April 2, 2024 | markets.businessinsider.comShort Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Expands By 10.0%March 17, 2024 | marketbeat.comMilestone rallies 23% on FDA update for tachycardia drugFebruary 26, 2024 | msn.comAnebulo Pharmaceuticals: Strong Buy Rating Amid Promising Clinical Advances and Rapid FDA TrackFebruary 16, 2024 | markets.businessinsider.comNew Debt & Financing Risk for Anebulo Pharmaceuticals, Inc. – What’s the Latest?February 15, 2024 | msn.comSubstance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication DrugFebruary 14, 2024 | msn.comAnebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Large Decline in Short InterestFebruary 14, 2024 | marketbeat.comAnebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent UpdatesFebruary 13, 2024 | finance.yahoo.com Get Anebulo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANEB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ANEB Media Mentions By Week ANEB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANEB News Sentiment▼0.000.63▲Average Medical News Sentiment ANEB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANEB Articles This Week▼30▲ANEB Articles Average Week Get the Latest News and Ratings for ANEB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Anebulo Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CytomX Therapeutics News Contineum Therapeutics News Canopy Growth News Abeona Therapeutics News Rocket Pharmaceuticals News Aldeyra Therapeutics News Korro Bio News Altimmune News 4D Molecular Therapeutics News Tectonic Therapeutic News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANEB) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThis Crypto Could Thrive as Global Tensions Rise Right as capital begins to rotate back into crypto, my top...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anebulo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANEB Stock Alerts